Trial Profile
Effect of EP-100 in triple negative breast cancer
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 21 Mar 2016
Price :
$35
*
At a glance
- Drugs EP 100 (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- Sponsors Esperance Pharmaceuticals
- 21 Mar 2016 New trial record